Department of Radiology

Publications

2018

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 2018;19(4):244-328.

Gabr MT, F Pigge C. Rhenium Complexes of Bis(benzothiazole)-Based Tetraarylethylenes as Selective Luminescent Probes for Amyloid Fibrils. Chemistry. 2018;24(45):11729-11737.

Wen Y, Nguyen TD, Liu Z, Spincemaille P, Zhou D, Dimov A, et al. Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation. Magn Reson Med. 2018;79(3):1545-1552.

Zhang S, Nguyen TD, Zhao Y, Gauthier SA, Wang Y, Gupta A. Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions. Neuroimage Clin. 2018;18:143-148.

Liu Z, Spincemaille P, Yao Y, Zhang Y, Wang Y. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med. 2018;79(5):2795-2803.

Gorman AW, Deh KM, Schwiedrzik CM, White JR, Groman EV, Fisher CA, et al. Brain Iron Distribution after Multiple Doses of Ultra-small Superparamagnetic Iron Oxide Particles in Rats. Comp Med. 2018;68(2):139-147.

Chen J, Li Y, Pirraglia E, Okamura N, Rusinek H, de Leon MJ. Quantitative evaluation of tau PET tracers F-THK5351 and F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization. Eur J Nucl Med Mol Imaging. 2018;45(9):1596-1604.

Kundel V, Trivieri MG, Karakatsanis NA, Robson PM, Mani V, Kizer JR, et al. Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath. 2018;22(4):1125-1135.

Lameijer M, Binderup T, van Leent MM, Senders ML, Fay F, Malkus J, et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. Nat Biomed Eng. 2018;2(5):279-292.

de Leon MJ, Blennow K. Therapeutic potential for peripheral clearance of misfolded brain proteins. Nat Rev Neurol. 2018;14(11):637-638.